Antibody evasion by the P.1 strain of SARS-CoV-2
31 Mar, 2021 | 03:36h | UTCAntibody evasion by the P.1 strain of SARS-CoV-2 – Cell
Commentary on Twitter (thread – Click for more)
An in-depth assessment of the P.1 (Brazil) variant
—less immune evasion than B.1.351 (South Africa) variant despite similar receptor binding domain mutations
—very good neutralization by mRNA vaccine via sera from vaccineshttps://t.co/2m0A1Pjs9O @CellCellPress today pic.twitter.com/uyV2eZdLQ9— Eric Topol (@EricTopol) March 30, 2021